Advancing Biopharmaceutical Safety Through US Host Cell Contaminant Testing Market Innovations
The US Host Cell Contaminant Testing Market Size is projected to surge dramatically, reaching approximately 245.42 million USD by 2035, up from 86.46 million USD in 2024. This growth trajectory represents a compound annual growth rate (CAGR) of 9.95%, indicating robust advancements in biopharmaceutical testing methodologies. Host cell contaminants, known for destabilizing therapeutic drug...
0 Comments 0 Shares 72 Views 0 Reviews